Bone Marrow Transplantation for Multiple Sclerosis
90.3% of cases are Progression Free after 5 years
78.5% of patients achieve no evidence of disease activity at 5 Years
1.02 points improvement in the EDSS (disability) score within 1 year
No grade-4 side effects or deaths were recorded
After years of heated debates, it was recently proved that Bone Marrow Transplantation (BMT) can achieve better results compared to the advanced drug therapy currently approved for some Multiple Sclerosis (MS) patients.
The results were recently published in the prestigious Journal of the American Association (JAMA).
With our international partnership with a world-leading hematological center in Beijing, China, we enable you to access what seems to be the next generation of Multiple Sclerosis treatments.
Our partners successfully complete over 500 Bone Marrow Transplantations each year, including treatments for MS.
Recent studies show the benefit of Nonmyeloablative Hematopoietic Stem Cell Transplantation compared to the current MS treatments
How to apply for Multiple Sclerosis BMT/HSCT Treatment?
+ Fill in the below form and our case manager will contact and send you the hospital questionnaire indicated for Multiple Sclerosis patients considering BMT/HSCT
BMT’s effectiveness for Multiple Sclerosis
According to a globally conducted study, Bone Marrow Transplantation was found safe and effective in treating Multiple Sclerosis with exceptional results!
While 34 patients receiving the standard therapy progressed during the follow-up only 3 patients receiving the BMT progressed.
Also, the disability scores (EDSS) for the BMT patients decreased during the follow-up while increasing in the group receiving the standard Disease Modifying Therapy (DMT).
Safety and Adverse Effects
According to the study there were no deaths and no nonhematopoietic grade 4 toxicities (such as myocardial infarction, sepsis, or other disabling or life-threatening events).
Who Can Benefit from the treatment?
The international study shows that Bone Marrow Transplantation is most helpful for Relapsing-Remitting Multiple Sclerosis (MS) patients who experience disease progression or remission under standard treatment.
Hospital of Haemato-oncology, Beijing, China
The Hospital is specialized in leukemia, myeloma, lymphomas and malignant anemia. With more than 500 CAR-T treatments preformed, the hospital is one of the largest centers in the world in the CAR-T field. The in-house specialists are also world-class bone marrow transplantation experts, with more than 700 transplantations annually.
The Science behind HSCT for MS
Multiple Sclerosis is known to be an autoimmune disease.
Therefore, Bone Marrow Transplantation that 'reboots' your immune-system can change dramatically the course of the disease.
This treatment mechanism was shown to be helpful in several laboratory studies and recently in clinical trials with 100 patients.
What about cost-effectivness?
The current annual cost of disease-modifying drug therapy is approximately $65,000. Therefore, BMT is cost-efficient in the long run, and achieves better clinical results.
As part of our treatment package, we provide:
Online medical consultancies about the efficacy of treatment for you
Treatment in a leading, experienced medical center in Israel or China
Travel and accommodation arrangements (on request)
All airport and hospital transfers
Multi-lingual support and local escort teams, also providing translations for your medical documentations
Contact us: fill this form, send an email or give us a call.
Send us your medical documents. We will translate and forward them to the hospital's experts.
We will send you the various possible treatment plans and prices, and help you select the best option for you.
If you’d like, we can help in organizing your flights and accommodation.
Our personal attendant will meet you at the arrival gate and accompany you throughout the course of your treatment.
We will send the translated release documents and keep in touch with you even after you leave.
Always here for you,
The GHD Team